No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
RGEN250117C120000
- 27.30
- +6.80+33.17%
15min DelayClose Dec 20 16:00 ET
29.66High27.30Low
29.66Open20.50Pre Close4 Volume0 Open Interest120.00Strike Price11.39KTurnover66.04%IV1.97%PremiumJan 17, 2025Expiry Date24.46Intrinsic Value100Multiplier25DDays to Expiry2.84Extrinsic Value100Contract SizeAmericanOptions Type0.8788Delta0.0080Gamma5.46Leverage Ratio-0.1117Theta0.0700Rho4.80Eff Leverage0.0768Vega
Intraday
- 5D
- Daily
News
Repligen Corporation (RGEN) Fell Along With Peers
Repligen Initiated at Hold by Canaccord Genuity
Repligen Analyst Ratings
CCORF Initiates Repligen(RGEN.US) With Hold Rating, Announces Target Price $165
Express News | BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors
Press Release: BioLife Solutions Appoints Tony J. Hunt to Its Board of Directors